188 related articles for article (PubMed ID: 34935947)
1. Estrogen and Progesterone Therapy and Meningiomas.
Hage M; Plesa O; Lemaire I; Raffin Sanson ML
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.
Devalckeneer A; Aboukais R; Bourgeois P; De Witte O; Racape J; Caron S; Perbet R; Maurage CA; Lejeune JP
Clin Neurol Neurosurg; 2021 Nov; 210():106959. PubMed ID: 34592677
[TBL] [Abstract][Full Text] [Related]
3. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.
Weill A; Nguyen P; Labidi M; Cadier B; Passeri T; Duranteau L; Bernat AL; Yoldjian I; Fontanel S; Froelich S; Coste J
BMJ; 2021 Feb; 372():n37. PubMed ID: 33536184
[TBL] [Abstract][Full Text] [Related]
4. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
[TBL] [Abstract][Full Text] [Related]
5. Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome.
Graillon T; Boissonneau S; Appay R; Boucekine M; Peyrière H; Meyer M; Farah K; Albarel F; Morange I; Castinetti F; Brue T; Fuentes S; Figarella-Branger D; Cuny T; Dufour H
Neurochirurgie; 2021 Nov; 67(6):556-563. PubMed ID: 33989642
[TBL] [Abstract][Full Text] [Related]
6. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma.
Samarut E; Lugat A; Amelot A; Scharbarg E; Hadjadj S; Primot C; Loussouarn D; Thillays F; Buffenoir K; Cariou B; Drui D; Roualdes V
J Neurooncol; 2021 Mar; 152(1):115-123. PubMed ID: 33392938
[TBL] [Abstract][Full Text] [Related]
7. Opposed evolution of the osseous and soft parts of progestin-associated osteomeningioma after progestin intake discontinuation.
Florea SM; Passeri T; Abbritti R; Bernat AL; Fontanel S; Yoldjian I; Funck-Brentano T; Weill A; Mandonnet E; Froelich S
J Neurosurg; 2023 Oct; 139(4):944-952. PubMed ID: 36883659
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.
Lee KS; Zhang JJY; Kirollos R; Santarius T; Nga VDW; Yeo TT
Sci Rep; 2022 Feb; 12(1):1942. PubMed ID: 35121790
[TBL] [Abstract][Full Text] [Related]
9. Meningioma in patients exposed to progestin drugs: results from a real-life screening program.
Samoyeau T; Provost C; Roux A; Legrand L; Dezamis E; Plu-Bureau G; Pallud J; Oppenheim C; Benzakoun J
J Neurooncol; 2022 Oct; 160(1):127-136. PubMed ID: 36066786
[TBL] [Abstract][Full Text] [Related]
10. Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
Passeri T; Giammattei L; Le Van T; Abbritti R; Perrier A; Wong J; Bourneix C; Polivka M; Adle-Biassette H; Bernat AL; Masliah-Planchon J; Mandonnet E; Froelich S
Acta Neurochir (Wien); 2022 Jan; 164(1):255-263. PubMed ID: 34613529
[TBL] [Abstract][Full Text] [Related]
11. Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas.
Apra C; Roblot P; Alkhayri A; Le Guérinel C; Polivka M; Chauvet D
J Neurooncol; 2020 Aug; 149(1):95-101. PubMed ID: 32705456
[TBL] [Abstract][Full Text] [Related]
12. Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.
Champagne PO; Passeri T; Froelich S
Acta Neurochir (Wien); 2019 Mar; 161(3):589-592. PubMed ID: 30666456
[TBL] [Abstract][Full Text] [Related]
13. First case of cyproterone acetate induced multiple meningiomas in identical female twins: A case report.
Batchinsky-Parrou V; Barraud S; Kleiber JC; Litre F
Neurochirurgie; 2022 Apr; 68(3):323-326. PubMed ID: 33989640
[TBL] [Abstract][Full Text] [Related]
14. [Meningioma under progestin treatment : what attitude to adopt ?].
Cornu E; Pintiaux A; Reuter G; Kridelka F; Pétrossians P; Potorac I
Rev Med Liege; 2023 Oct; 78(10):550-557. PubMed ID: 37830319
[TBL] [Abstract][Full Text] [Related]
15. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
Piper JG; Follett KA; Fantin A
Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172
[TBL] [Abstract][Full Text] [Related]
16. New Insights into Expression of Hormonal Receptors by Meningiomas.
Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B
World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078
[TBL] [Abstract][Full Text] [Related]
17. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
[TBL] [Abstract][Full Text] [Related]
18. Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
J Neurooncol; 2018 Jan; 136(2):327-333. PubMed ID: 29081037
[TBL] [Abstract][Full Text] [Related]
19. Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient.
Cebula H; Pham TQ; Boyer P; Froelich S
Acta Neurochir (Wien); 2010 Nov; 152(11):1955-6. PubMed ID: 20811919
[No Abstract] [Full Text] [Related]
20. Hormonal therapies and meningioma: is there a link?
Cea-Soriano L; Blenk T; Wallander MA; Rodríguez LA
Cancer Epidemiol; 2012 Apr; 36(2):198-205. PubMed ID: 21943794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
